COMMUNIQUÉS West-GlobeNewswire

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31/07/2026
VANCOUVER, BC and BOSTON, MA, July 31, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and [...]
Precipio Announces Q2-2026 Shareholder Update Call
31/07/2026
Conference Call will be held on August 17th, 2026, at 5:00 PM EDT NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q2-2026 [...]
XORTX Announces Director Resignation
31/07/2026
CALGARY, Alberta, July 31, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing [...]
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
31/07/2026
Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient population PSMAddition updated results show Pluvicto reduced risk of progression or death by 33% in combination with [...]
Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs
31/07/2026
BERKELEY, Calif., July 31, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, announces the signing of an Option Agreement (the “Agreement [...]
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
31/07/2026
MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook [...]
Cannabix Technologies Annual General Meeting Results
31/07/2026
VANCOUVER, British Columbia, July 31, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) announces the results of its annual general meeting of [...]
Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
31/07/2026
TEL AVIV, July 31, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda [...]
EUROAPI_Mise à disposition du Rapport Financier Semestriel 2026
31/07/2026
Communiqué de presse Paris, le 31 juillet 2026 Mise à disposition du Rapport financier semestriel 2026 EUROAPI a mis en ligne ce jour ses Etats Financiers semestriels consolidés condensés 2026 pour la période close le [...]
Human Appeal USA Announces "The Biggest Comedy Show" 2026 Tour: A 25-City Nationwide Event Where Every Laugh Gives Back to Global Humanitarian Relief
31/07/2026
MISSION VIEJO, Calif., July 31, 2026 (GLOBE NEWSWIRE) -- Human Appeal USA, a humanitarian nonprofit, announced the Biggest Comedy Show 2026 tour, which will launch this fall across 25 U.S. cities. The tour unites [...]
Turkish Airlines Sports Club Women’s Volleyball Team Completes Pre-Season Health Checks at Medicana
31/07/2026
The renewed healthcare sponsorship brings together one of Turkiye’s leading volleyball teams and Medicana Health Group’s multidisciplinary expertise in athlete health and preventive care ISTANBUL, July 31, 2026 (GLOBE [...]
EUROAPI_Availability of 2026 Half-year results financial report
31/07/2026
Press Release Paris, 31 July 2026 Availability of 2026 Half-Year Financial Report EUROAPI posted today its 2026 condensed Half Year Consolidated Financial Statements for the six months ended June 30, 2026. This document [...]
Moleculin Announces Pricing of $9.3 Million Public Offering
31/07/2026
HOUSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced the pricing of a best-efforts public offering of an aggregate of 12,376,667 shares of [...]
Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026
31/07/2026
–First public scientific presentation provides the biomedical engineering community with its first detailed view of the next-generation total artificial heart platform– TUCSON, Ariz., July 31, 2026 (GLOBE NEWSWIRE) -- [...]
Vistagen Appoints Douglas J. Williamson to its Board of Directors
31/07/2026
Dr. Williamson brings nearly three decades of leadership experience in neuroscience drug development, clinical research, and regulatory strategy SOUTH SAN FRANCISCO, Calif., July 31, 2026 (GLOBE NEWSWIRE) -- Vistagen ( [...]
Jushi Holdings Inc. Completes Redomicile from British Columbia to Nevada
31/07/2026
BOCA RATON, Fla., July 31, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSH ), a vertically integrated, multi-state cannabis operator, today announced the completion of [...]
SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics
31/07/2026
TEL AVIV, Israel, July 31, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company [...]
IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
31/07/2026
Announces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance Reports revenue of $20.5 million for the second quarter of 2026, which increased by $0.1 million, or 0. [...]
Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients
31/07/2026
Prior venetoclax failure — a setting in which published salvage remission rates are approximately 13% and median survival approximately 2.4 months — shows no adverse impact on blinded composite remission rates as [...]

Pages